Writing

Comment on the CY 2027 OPPS proposed rule supporting separate NPIs for off-campus provider-based departments and asking CMS to carry the identifiers through to Transparency in Coverage and hospital price files, align NPPES with consumer-facing names and publish a public NPI crosswalk. Co-signed with Checkbook/CSS, Defacto Health, Milliman, PatientRightsAdvocate.org, PurpleLab and Visible Charges.

Six theses about how AI changes healthcare go-to-market work and outcomes-based pricing. Co-authored with Harrison Lieberfarb.

Summarizes changes to payer reporting schema and enforcement timelines. Co-authored with Carol Skenes.

Highlights of Turquoise Health's comment on the CY 2026 OPPS/ASC proposed rule: enforceable Advanced EOBs and thoughtful machine-readable-file standards. Co-authored with Carol Skenes.

Analyzes CMS hospital price transparency accuracy and completeness proposals. Co-authored with Carol Skenes and Chris Severn.

Argues prescription drug rates must be included for usable transparency. Co-authored with Chris Severn.

Discusses the next phase of transparency policy and implementation.

Explains the implications of a federal drug-pricing executive order.

Discusses bipartisan federal support for healthcare price transparency. Co-authored with Chris Severn.

Three mistakes that keep hospital machine-readable files from passing the CMS validator after the CY 2024 OPPS rule, and simple fixes for each. MedCity Influencers.

Reviews federal hospital pricing enforcement and compliance changes. Co-authored with Carol Skenes.

Discusses pricing dataset needs for specialty providers.

Guidance for organizations sourcing and evaluating healthcare pricing data.

Practical hospital machine-readable-file compliance checklist.

Where the rate-publication timeline left off after 2021 and 2022, and what 2023 asks for instead: patient-facing estimates, Good Faith Estimates for self-pay patients and payer cost tools.

Discusses localized applications of healthcare price-transparency data.

Examines transparency challenges for ambulatory surgery and imaging providers.

Explains how single-case agreements can reduce out-of-network therapy costs.